Register Today for this Free Webinar Series!


Industry interest in continuous bioprocessing is rapidly increasing, yet questions remain about best practices for effective integration. In 2016, Pall Life Sciences delivered on a promise to bring novel continuous solutions to the market, while sharing the hows and whys of transitioning from batch to semi- and fully-continuous bioprocesses.

In the first part of this webinar series, key customers align with our team to highlight the advantages of continuous operations, and how novel technologies, such as continuous multi-column chromatography, are already impacting drug development.




Webinar 3

Continuous Bioprocessing Solutions: An Update on Significant Enabling Technology Advances

March 7, 2017 
8:00 am Greenwich Mean Time 
9:00 am Central European Time 
1:30 pm Indian Standard Time 
4:00 pm Singapore Standard Time 
5:00 pm Japanese Standard Time

While continuous processing has been applied for several decades, the highly regulated biopharm industry has just started to embrace this approach. The team at Pall Life Sciences has leveraged an industry-leading single-use portfolio to deliver innovative continuous bioprocessing solutions to the market. Join our team as they detail the development journey, and highlight critical advances to date.

Presenter:
Peter Levison, PhD
Senior Marketing Director,
Downstream Processing
Pall Life Sciences
(Portsmouth, UK)

Moderator:
Jon Petrone
Senior Director,
SLS Bioprocess
Integration Team
Pall Life Sciences
(Westborough, MA)



Webinar 1

Case Study: CMC Biologics Explores the Potential of Continuous Multi-Column Chromatography

Available On Demand

The Protein A capture chromatography step for monoclonal antibodies (mAbs) is both costly and challenging. Recent advances in continuous multi-column chromatography have drawn great interest due to the potential to dramatically lower the cost and complication of this key purification step in both semi- or fully continuous application. In this webinar, you will learn more about the practical application of continuous multi-column chromatography from the team at CMC Biologics and Pall Life Sciences.

Presenter:
Michelle Najera, PhD
CMC Biologics
Downstream Process
Development Scientist
(Seattle, WA)

Moderator and Presenter:
Lynne Frick
Director of Sales
Continuous Bioprocessing
Pall Life Sciences
(Westborough, MA)



Webinar 2

Case Study: Merck Presents Scale-up of Continuous Chromatography using Cadence BioSMB Process System

Available On Demand

In the present study, the development of a continuous Protein A chromatography process step using KANEKA KanCapA for the capture of a therapeutic mAb is described. The method was developed initially in a batch mode and then transferred to the Cadence BioSMB PD system. This five column process was then successfully scaled-up 150-fold using the Cadence BioSMB Process system. The entire process development and scale-up was completed within four weeks and described in detail along with the process economic benefits of using multi-column chromatography.


Presenter:
Mark Brower
Merck & Co.
Senior Research Chemical Engineer
(Kenilworth, NJ)

Moderator and Presenter:
Marc Bisschops, PhD
Principal Scientist,
Continuous Bioprocessing
Pall Life Sciences
(Hague, Netherlands)


Already Registered? Log In Now

Complete this form to enter the webcast.
(* "indicates required field)

  • Yes
  • No
  • Yes
  • No
  • Vaccines
  • Antibody Drug Conjugates
  • Gene Therapy
  • Cell Therapy
  • Biotechnology
  • Chemical API/Antibiotics
  • Plasma/Biologicals
  • Formulation and Filling
  • Utilities (gas, air & water)
  • CMO
  • Other
  • Cell Culture / Fermentation
  • Clarification / Cell Removal
  • Concentration / Diafiltration
  • Purification
  • Viral Clearance
  • Continuous Processing
  • Single-Use Technologies
  • Formulation and Filling
  • QC / Analytics
  • Other